By The University of Osaka
Researchers from The University of Osaka found that a one-time genome editing treatment introducing a gene encoding the glucagon-like peptide-1 receptor agonist Exendin-4, marketed as the weight-loss drug Exenatide, results in sustained secretion of the drug, reduced food intake, and enhanced weight
0 Komentar untuk "Daily Digest: Make-your-own weight-loss drug using an innovative genome editing approach, and more ..."